Tag : opioid abuse

Neurology

COVID-19 Prompts 'Lifesaving' Policy Change for Opioid Addiction

Newsemia
In the face of COVID-19, SAMHSA has announced policy changes that will allow some patients in treatment for opioid use disorder to receive a 28-day...
Latest News

COVID-19 Prompts 'Lifesaving' Policy Change for Opioid Addiction

Newsemia
In the face of COVID-19, SAMHSA has announced policy changes that will allow some patients in treatment for opioid use disorder to receive a 28-day...
Neurology

FDA Okays First Generic Naloxone Nasal Spray for Opioid Overdose

Newsemia
The FDA has granted final approval for the first generic naloxone hydrochloride nasal spray for reversing or stopping the effects from an opioid overdose. FDA...
Neurology

Stop Limiting Access to Opioid Addiction Meds, Experts Say

Newsemia
A new report from the National Academies of Science seeks expanded use of methadone, buprenorphine, and naltrexone to help patients combat opioid use disorder. Medscape...
Neurology

FDA Panel Fails to Support Novel Opioid for Depression

Newsemia
An FDA advisory panel failed to endorse the approval of a novel opioid to treat major depressive disorder because of insufficient efficacy data. News Alerts...
Neurology

FDA Turns Down Abuse-Deterrent Remoxy ER for Pain

Newsemia
The FDA has followed its Advisory Committee’s earlier recommendation and nixed approval of abuse-deterrent oxycodone extended-release capsules (Remoxy ER) for severe pain. FDA Approvals Source...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy